Micronutrients decrease incidence of common infections in type 2 diabetic outpatients
Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue, Yinghua Liu, Hongjiang Jing, Jin Wang, Rongxin Zhang, Yuehong Zhang, Yong Zhang, Qing Xu, Xiaoming Yu, Changyong Xue
Abstract
A randomized, double-blind, placebo-controlled trial was carried out to investigate the effects of micronutrients supplementation on immunity and the incidence of common infections in type 2 diabetic outpatients. A total of 196 type 2 diabetic outpatients were randomized to receive tablets of micronutrients (n=97) or placebo (n=99) for 6 months. Individualized dietary energy intake and daily physical activity were recommended. Anthropometric measurements, blood biochemical variables and the incidence of common infections were measured at baseline and at 6 months. Data on diet, exercise and infection (upper respiratory tract infection, skin infection, urinary and genital tract infections, other infections) were recorded 1 month before the study and every month during the study. Blood concentrations of total protein, iron (Fe), folic acid and hemoglobin increased and unsaturated iron-binding capacity(UIBC) levels were decreased in the micronutrients supplementation group compared to the placebo group at 6 months. Moreover, at 6 months, compared to the placebo group, the blood concentrations of IgE, CD4+, CD4+/CD8+, WBC, lymphocyte counts, basophilic leukocyte increased and CD8+ count decreased in the supplementation group, and the levels of IgA, IgM, IgG and complements C3 and C4 did not differ. The incidence of upper respiratory infection, whitlow, dermapostasis, vaginitis, urinary tract infection, gingivitis and dental ulcer were lower and body temperature and duration of fever greatly improved in the supplementation than the placebo group. These data indicated that supplementation of micronutrients might increase immune function and reduce the incidence of common infections in type 2 diabetic outpatients.
Source: PubMed
Upcoming Clinical Trials
-
Inna Chen, MDHaukeland University Hospital; Azienda Ospedaliera di Padova; Hospital Universitario... and other collaboratorsNot yet recruitingPancreatic CancerDenmark, Italy, Norway, Romania, Spain
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Breathe Arts Health ResearchNot yet recruitingRehabilitation | Geriatric | Older Adults (65 Years and Older)United Kingdom
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruitingHeredo Familial Tumors | Psycho Oncological SupportItaly
-
Hansoh BioMedical R&D CompanyNot yet recruitingPlatinum-sensitive Recurrent Ovarian CancerChina
-
Indiana UniversityMoi University; AudereNot yet recruitingAutism Spectrum DisorderUnited States, Kenya
-
Assiut UniversityNot yet recruitingPremature Birth | Bronchopulmonary Dysplasia | Respiration Failure
-
Assiut UniversityNot yet recruitingInflammatory Bowel Diseases | Crohn Disease | Pediatric Crohns Disease
-
Eisai Inc.RecruitingAlzheimer's DiseaseUnited States
-
Emory UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Not yet recruitingHuman Immunodeficiency VirusUnited States
-
AbbVieNot yet recruiting
-
Adraxe Corp.Not yet recruitingEpilepsy (Treatment Refractory)United States